Valion Bio, Inc. (VBIO)
2.50
-0.27
(-9.75%)
USD |
NASDAQ |
Sep 08, 16:00
2.45
-0.05
(-2.00%)
Pre-Market: 09:13
Valion Bio Total Assets (Quarterly) : 32.47M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.47M |
| March 31, 2026 | 38.22M |
| December 31, 2025 | |
| September 30, 2025 | 6.229M |
| June 30, 2025 | 4.508M |
| March 31, 2025 | 3.777M |
| December 31, 2024 | 2.807M |
| September 30, 2024 | 3.394M |
| June 30, 2024 | 4.783M |
| March 31, 2024 | 3.286M |
| December 31, 2023 | 5.254M |
| September 30, 2023 | 7.007M |
| Date | Value |
|---|---|
| June 30, 2023 | 4.596M |
| March 31, 2023 | 7.101M |
| December 31, 2022 | 6.018M |
| September 30, 2022 | 8.208M |
| June 30, 2022 | 11.03M |
| March 31, 2022 | 12.69M |
| December 31, 2021 | 15.04M |
| September 30, 2021 | 1.981M |
| June 30, 2021 | 2.534M |
| March 31, 2021 | 15.04M |
| December 31, 2020 | 1.531M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Outlook Therapeutics, Inc. | 26.18M |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.59M |
| Shareholders Equity (Quarterly) | 11.88M |
| Debt to Equity Ratio | 1.465 |
| Current Ratio | 1.110 |
| Net Debt Paydown Yield | -161.3% |